Full Coverage

Tonix Pharmaceuticals seeks FDA approval for new fibromyalgia drug

Tonix Pharmaceuticals Presented Data and Analyses of TNX-102 SL Treatment Effects on Fibromyalgia at the Annual European Congress of Rheumatology (EULAR) 2025

5 days ago

New Data Support TNX-102 SL Efficacy Ahead of PDUFA

4 days ago

By Victoria Johnson

Tonix Pharma Presents Data at Rheumatology Congress

5 days ago

Search

Clear search

Close search

Google apps

Main menu